跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUGAMMADEX BAXTER 100 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUGAMMADEX BAXTER 100 MG/ML SOLUCION INYECTABLE EFG
Approved
STANDARD
SUGAMMADEX BAXTER 100 MG/ML SOLUCION INYECTABLE EFG
Baxter Holding B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 21, 2023
Approval ID
c9a2c63b6ab43846
Company
Baxter Holding B.V.
Type
Standard
Approval Details
Approval Id
c9a2c63b6ab43846
Drug Cima Aemps Name
SUGAMMADEX BAXTER 100 MG/ML SOLUCION INYECTABLE EFG
Register Number
88983
Holder Company Name
Baxter Holding B.V.
Marketing Company Name
Baxter S.L.
Holder Company Detail Path
/organization/baxter-holding-bv
Authorization Date
2023-07-21
Dosage Form
SOLUCIÓN INYECTABLE
Dose
100 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Baxter Holding B.V.
Company Detail Path
/organization/baxter-holding-bv
Company Information
Pharmaceutical Company Name
Baxter Holding BV
Country Name
Netherlands
Active Ingredients
SUGAMMADEX
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 21, 2023
Approval ID
c9a2c63b6ab43846
Type
Standard
Back to CIMA-AEMPS Approvals
